Form D

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
THERAPEUTICSMD, INC.
Jurisdiction of Incorporation/Organization
NE
Year of Incorporation/Organization
2010

Previous Name(s)

  • AMHN, INC.
  • CROFF ENTERPRISES INC
  • CROFF OIL CO
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

951 BROKEN SOUND PARKWAY NW
SUITE 320
BOCA RATON, FL 33487
Phone Number: subscription required

Item 3. Related Persons

Name
ROBERT G. FINIZIO
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JOHN C.K. MILLIGAN IV
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
DANIEL A. CARTWRIGHT
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
MITCHELL L. KRASSAN
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
BRIAN BERNICK, M.D.
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
TOMMY G. THOMPSON
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
SAMUEL A. GRECO
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
COOPER C. COLLINS
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
ROBERT V. LAPENTA, JR.
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
NICHOLAS SEGAL
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 4. Industry Group

PHARMACEUTICALS

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

New Notice
Date of First Sale in this Offering:
09/26/2012

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
0

Item 12. Sales Compensation

Recipient
JEFFERIES COMPANY, INC.
Recipient CRD Number
2347
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
520 MADISON AVENUE
16TH FLOOR
NEW YORK, NY 10022
States of Solicitation
  • CA
  • CO
  • CT
  • FL
  • MA
  • NJ
  • NY
  • PA

Item 13. Offering and Sales Amounts

Total Offering Amount
8500001
Total Amount Sold
8500001
Total Remaining to be Sold
0
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
8

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
552500.0
Finders' Fees
0.0
Clarification of Response
THE AMOUNT REPRESENTS FEES EARNED BY JEFFERIES COMPANY, INC. FOR ITS SERVICES AS EXCLUSIVE PLACEMENT AGENT.

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response

Signature and Submission

Issuer Name
THERAPEUTICSMD, INC.
Issuer Signature
/S/ DANIEL A. CARTWRIGHT
Signer Name
DANIEL A. CARTWRIGHT
Signer Title
CHIEF FINANCIAL OFFICER
Signature Date
10/10/2012
WhaleWisdom Logo

Elevate your investments